Drug Type Small molecule drug |
Synonyms IHP 102, IHP102 |
Action modulators, inhibitors |
Mechanism P-sel modulators(P-selectin modulators), complement factor inhibitors(Complement Factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lung Injury | Preclinical | United States | 01 Jul 2025 | |
Solid tumor | Preclinical | United States | 01 Jul 2025 | |
Vaso-occlusive crisis | Preclinical | United States | 08 Sep 2023 | |
Anemia, Sickle Cell | Preclinical | United States | 12 Dec 2022 | |
Anemia, Sickle Cell | Preclinical | United States | 12 Dec 2022 |